Adding Vimpat Significantly Reduces Partial-Onset Seizures In Adults With Epilepsy - Study The new antiepileptic drug Vimpat® (lacosamide) demonstrated significantly fewer seizures in adult partial-onset epilepsy patients whose seizures were inadequately controlled despite taking up to three other AEDs, according to a Phase III clinical study published online in Epilepsia. In the study, seizure reduction was measured by: Primary Endpoints The change in seizure frequency per 28 days from baseline to the maintenance period.
Source: www.medicalnewstoday.comPCTs Failing In Legal Duty To Provide Computerised CBT, UK Approximately one third Primary Care Trusts (PCTs) are failing in their legal obligation to provide computerised cognitive behavioural therapy (cCBT) to patients, according to an article published today in Pulse. Trusts blame financial cutbacks or a lack of funding for the failure to commission cCBT services, almost three years after the publication of a mandatory NICE technology appraisal.
Source: www.medicalnewstoday.comPSD502 For Premature Ejaculation - Positive Outcomes From European Phase III Pivotal Trial Plethora Solutions Holdings PLC ("Plethora" or the "Company", AIM: PLE), the specialist developer of products for the treatment and management of urological disorders, announces that its European Phase III double-blind placebo controlled study of PSD502 for the treatment of premature ejaculation (PE) has met its three co-primary endpoints of Intra-vaginal Ejaculation Latency Time ('IELT') and Index of Premature Ejaculation ('IPE'; Ejaculatory Control and Sexual Satisfaction domains).
Source: www.medicalnewstoday.comVIVUS Initiates Avanafil Phase 3 Trials For Males With Erectile Dysfunction VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced it has initiated the first of several pivotal phase 3 studies of avanafil, our investigational product for the treatment of erectile dysfunction (ED). Avanafil is a next-generation, fast-acting, selective, investigational oral phosphodiesterase type 5 (PDE5) inhibitor.
Source: www.medicalnewstoday.comBPA Plastic May Stay In Body Longer A new study by scientists in the US found surprisingly that for some people, the controversial plastics chemical bisphenol A (BPA). lingered in the body at high levels for much longer than was assumed, even after fasting for 24 hours, suggesting that BPA either does not metabolize rapidly, or is coming from non-food sources, or both.
Source: www.medicalnewstoday.comTadpoles May Hold Key To Skin Cancer Treatment Scientists doing groundbreaking research in the UK have suggested tadpoles may hold the key to developing new drugs to treat skin cancer. There is a study about it in the latest issue of the Cell Press journal Chemistry & Biology published on 30 January.
Source: www.medicalnewstoday.comPenile Fracture Happens In Real Life Not Just On Grey's Anatomy An episode of American hospital drama Grey's Anatomy screened in the US last week has led to thousands of young men scouring the internet to find out if it really is possible for a man to fracture his penis, as happened to on-screen Consultant Mark Sloan (aka McSteamy, played by Eric Dane) when he had sex in the on-call room with intern Lexie Grey (played by Chyler Leigh).
Source: www.medicalnewstoday.comHigher Blood Glucose Linked To Lower Cognitive Function A sub-study of a trial looking at the effect of diabetes on heart disease risk found that higher levels of hemoglobin A1C levels (a measure of a person's average blood glucose over a 2 to 3 month period) were linked to lower cognitive function.
Source: www.medicalnewstoday.comPharmacy Chain Allows Men To Get Erectile Dysfunction Drugs Without Visiting Their GP, UK A new service which allows men to get erectile dysfunction drugs legitimately without having to visit their GP for a
prescription has been launched. The new service - a UK first - is being launched by Lloydspharmacy in partnership with sexual health experts
Source: www.medicalnewstoday.com
# posted by Network @ 4:34 PM
